Gerald B. Appel

31.4k total citations · 4 hit papers
203 papers, 13.6k citations indexed

About

Gerald B. Appel is a scholar working on Nephrology, Rheumatology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Gerald B. Appel has authored 203 papers receiving a total of 13.6k indexed citations (citations by other indexed papers that have themselves been cited), including 122 papers in Nephrology, 46 papers in Rheumatology and 33 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Gerald B. Appel's work include Renal Diseases and Glomerulopathies (114 papers), Systemic Lupus Erythematosus Research (40 papers) and Chronic Kidney Disease and Diabetes (32 papers). Gerald B. Appel is often cited by papers focused on Renal Diseases and Glomerulopathies (114 papers), Systemic Lupus Erythematosus Research (40 papers) and Chronic Kidney Disease and Diabetes (32 papers). Gerald B. Appel collaborates with scholars based in United States, United Kingdom and Canada. Gerald B. Appel's co-authors include Vivette D. D’Agati, Jai Radhakrishnan, Glen S. Markowitz, Andrew S. Bomback, Ellen M. Ginzler, Harold C. Neu, Mary Anne Dooley, Anthony M. Valeri, Conrad L. Pirani and Neil Solomons and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Journal of Clinical Investigation.

In The Last Decade

Gerald B. Appel

201 papers receiving 13.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: The lupus nephritis assessment with rituximab study

2012 972 citations Brad H. Rovin, Fernando C. Fervenza et al. profile →
Mycophenolate Mofetil or Intravenous Cyclophosphamide for Lupus Nephritis

2005 766 citations Gerald B. Appel et al. profile →
Mycophenolate Mofetil versus Cyclophosphamide for Induction Treatment of Lupus Nephritis

2009 734 citations Gerald B. Appel et al. Journal of the American Society of Nephrology profile →
Mycophenolate versus Azathioprine as Maintenance Therapy for Lupus Nephritis

2011 421 citations Gerald B. Appel et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Gerald B. Appel United States	63	8.1k	4.9k	3.3k	2.0k	1.9k	203	13.6k
Brad H. Rovin United States	67	7.2k 0.9×	7.9k 1.6×	6.0k 1.8×	2.1k 1.1×	3.4k 1.8×	342	19.2k
Lee A. Hebert United States	49	4.8k 0.6×	2.6k 0.5×	2.2k 0.7×	1.8k 0.9×	1.7k 0.9×	147	10.9k
Bruce A. Julian United States	64	9.1k 1.1×	1.3k 0.3×	3.5k 1.1×	1.7k 0.9×	2.3k 1.2×	219	13.6k
Glen S. Markowitz United States	63	7.0k 0.9×	1.3k 0.3×	1.7k 0.5×	2.5k 1.3×	3.7k 2.0×	195	13.5k
Sanjeev Sethi United States	65	8.1k 1.0×	1.9k 0.4×	3.6k 1.1×	2.7k 1.4×	4.8k 2.6×	287	13.1k
Christophe Legendre France	76	4.3k 0.5×	726 0.1×	3.6k 1.1×	1.8k 0.9×	1.5k 0.8×	426	18.5k
Dominique Nochy France	45	3.3k 0.4×	1.4k 0.3×	2.2k 0.7×	1.4k 0.7×	1.4k 0.7×	153	8.5k
Manuel Praga Spain	51	5.4k 0.7×	660 0.1×	1.1k 0.3×	1.9k 0.9×	1.8k 1.0×	330	10.7k
Tibor Nádasdy United States	44	3.7k 0.5×	1.7k 0.3×	1.3k 0.4×	1.7k 0.9×	2.1k 1.1×	175	9.0k
Samih H. Nasr United States	61	5.8k 0.7×	1.4k 0.3×	1.5k 0.4×	2.0k 1.0×	5.3k 2.8×	237	10.7k

Countries citing papers authored by Gerald B. Appel

Since Specialization

Citations

This map shows the geographic impact of Gerald B. Appel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gerald B. Appel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gerald B. Appel more than expected).

Fields of papers citing papers by Gerald B. Appel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gerald B. Appel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gerald B. Appel. The network helps show where Gerald B. Appel may publish in the future.

Co-authorship network of co-authors of Gerald B. Appel

This figure shows the co-authorship network connecting the top 25 collaborators of Gerald B. Appel. A scholar is included among the top collaborators of Gerald B. Appel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gerald B. Appel. Gerald B. Appel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Peleg, Yonatan, Miroslav Sekulic, Jae‐Hyung Chang, et al.. (2024). C3 Glomerulopathy Recurs Early after Kidney Transplantation in Serial Biopsies Performed within the First 2 Years after Transplantation. Clinical Journal of the American Society of Nephrology. 19(8). 1005–1015. 6 indexed citations

Barbour, Sean J., Fernando C. Fervenza, Paul Brenchley, et al.. (2023). Anti-PLA2R Antibody Levels and Clinical Risk Factors for Treatment Nonresponse in Membranous Nephropathy. Clinical Journal of the American Society of Nephrology. 18(10). 1283–1293. 21 indexed citations

Podos, Steven D., Howard Trachtman, Gerald B. Appel, et al.. (2022). Baseline Clinical Characteristics and Complement Biomarkers of Patients with C3 Glomerulopathy Enrolled in Two Phase 2 Studies Investigating the Factor D Inhibitor Danicopan. American Journal of Nephrology. 53(10). 675–686. 11 indexed citations

Wang, Minxian, Justin Chun, Giulio Genovese, et al.. (2019). Contributions of Rare Gene Variants to Familial and Sporadic FSGS. Journal of the American Society of Nephrology. 30(9). 1625–1640. 35 indexed citations

Chertow, Glenn M., Gerald B. Appel, Geoffrey A. Block, et al.. (2018). Effects of bardoxolone methyl on body weight, waist circumference and glycemic control in obese patients with type 2 diabetes mellitus and stage 4 chronic kidney disease. Journal of Diabetes and its Complications. 32(12). 1113–1117. 11 indexed citations

Pirani, Conrad L., Anthony M. Valeri, Vivette D. D’Agati, & Gerald B. Appel. (2015). Renal Toxicity of Nonsteroidal Anti-Inflammatory Drugs1. Contributions to nephrology. 55. 159–175. 15 indexed citations

Hogan, Jonathan & Gerald B. Appel. (2013). Update on the treatment of lupus nephritis. Current Opinion in Nephrology & Hypertension. 22(2). 224–230. 21 indexed citations

Bomback, Andrew S. & Gerald B. Appel. (2012). Pathogenesis of the C3 glomerulopathies and reclassification of MPGN. Nature Reviews Nephrology. 8(11). 634–642. 105 indexed citations

Huerta, Ana, Andrew S. Bomback, Vassilios Liakopoulos, et al.. (2011). Renal-limited 'lupus-like' nephritis. Nephrology Dialysis Transplantation. 27(6). 2337–2342. 43 indexed citations

10.

Bomback, Andrew S., Huijuan Song, Vivette D. D’Agati, et al.. (2010). A new apolipoprotein E mutation, apoE Las Vegas, in a European-American with lipoprotein glomerulopathy. Nephrology Dialysis Transplantation. 25(10). 3442–3446. 21 indexed citations

11.

Bomback, Andrew S., Gerald B. Appel, Jai Radhakrishnan, et al.. (2010). ANCA-associated glomerulonephritis in the very elderly. Kidney International. 79(7). 757–764. 61 indexed citations

12.

Appel, Gerald B., Meryl Waldman, & Jai Radhakrishnan. (2006). New approaches to the treatment of glomerular diseases. Kidney International. 70. S45–S50. 4 indexed citations

13.

Preddie, Dean C., Glen S. Markowitz, Jai Radhakrishnan, et al.. (2006). Mycophenolate Mofetil for the Treatment of Interstitial Nephritis. Clinical Journal of the American Society of Nephrology. 1(4). 718–722. 63 indexed citations

14.

Appel, Gerald B. & Meryl Waldman. (2006). The IgA nephropathy treatment dilemma. Kidney International. 69(11). 1939–1944. 87 indexed citations

15.

Nasr, Samih H., Glen S. Markowitz, Michael B. Stokes, et al.. (2003). Proliferative glomerulonephritis with monoclonal IgG deposits: A distinct entity mimicking immune-complex glomerulonephritis. Kidney International. 65(1). 85–96. 175 indexed citations

16.

Markowitz, Glen S., et al.. (2003). Membranous glomerulopathy and acute interstitial nephritis following treatment with celecoxib. Clinical Nephrology. 59(2). 137–142. 29 indexed citations

17.

Tsukaguchi, Hiroyasu, Akulapalli Sudhakar, Tu C. Le, et al.. (2002). NPHS2 mutations in late-onset focal segmental glomerulosclerosis: R229Q is a common disease-associated allele. Journal of Clinical Investigation. 110(11). 1659–1666. 143 indexed citations

18.

Radhakrishnan, Jai, et al.. (2001). Antiphospholipid antibody syndrome and renal disease. Current Opinion in Nephrology & Hypertension. 10(2). 175–181. 37 indexed citations

19.

Kambham, Neeraja, et al.. (1999). Heavy chain deposition disease: The disease spectrum. American Journal of Kidney Diseases. 33(5). 954–962. 57 indexed citations

20.

Appel, Gerald B., Norman J. Siegel, Alice Sue Appel, & John P. Hayslett. (1981). Studies on the mechanism of non-oliguric experimental acute renal failure.. PubMed Central. 54(4). 273–81. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact